CoChat

Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome

Gayathri, Ravichandran, Aruna, Thangavelu, Malar, Sivaraman, Shilpa, Bennur, Dhanasekar, Karukkupalayam Ramasamy · 2020 · International Journal of Colorectal Disease

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background The symptoms of irritable bowel syndrome (IBS) lead to considerable impairment of health-related quality of life and high health care costs. Available therapies are not efficient in treating the symptoms of IBS. Studies have shown the beneficial effects of Saccharomyces cerevisiae CNCM I-3856. Therefore, this study was done to evaluate the efficacy and safety of S. cerevisiae CNCM I-3856 in the treatment of IBS. Methods This was a prospective, randomized, placebo-controlled study. One hundred newly diagnosed subjects with IBS were subgrouped into IBS-D, IBS-C, and IBS-M and then randomized to the S. cerevisiae CNCM I-3856 and placebo groups. Saccharomyces cerevisiae/placebo was administered in addition to standard treatment for a period of 8 weeks. Subjects were assessed for improvement of abdominal pain and change in stool consistency using a 7-point Likert scale and Bristol stool scale respectively. Results The mean reduction of abdominal pain score in the S. cerevisiae CNCM I-3856 group was statistically significant when compared with the placebo group (p Conclusion The use of Saccharomyces cerevisiae CNCM I-3856 in IBS at a dose of 2 billion CFU twice daily for 8 weeks has shown to have an improvement in abdominal pain and stool consistency due to its analgesic and anti-inflammatory activity in subjects with IBS.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00384-019-03462-4

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 17 references

Cited by

Metadata

Authors
Gayathri, R., Aruna, T., Malar, S., Shilpa, B., & Dhanasekar, K. R.
Affiliations
Government Kilpauk Medical College (IN)
Corresponding author
Dhanasekar, Karukkupalayam Ramasamy
Venue
International Journal of Colorectal Disease
Published
2019-12-05
Volume
35
Issue
1
Pages
139-145
ISSN
  • 0179-1958 (ISSN-L)
  • 1432-1262
OpenAlex
W2993080746
Cited by
33
References
17
Citations by year
2026: 3 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 7 · 2020: 2
FWCI
3.87
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • International Journal of Colorectal Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
irritable bowel syndrome, probiotics, adjunctive therapy, abdominal pain, stool consistency, diarrhea-predominant irritable bowel syndrome, irritable bowel syndrome with constipation, IBS-M, health-related quality of life, anti-inflammatory activity, analgesic activity
MeSH terms
Adult, Feces, Female, Humans, Male, Saccharomyces cerevisiae, Abdominal Pain, Treatment Outcome, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome. https://app.cochat.ai/papers/10.1007/s00384-019-03462-4
The paper
Gayathri, R., Aruna, T., Malar, S., Shilpa, B., & Dhanasekar, K. R. (2020). Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-019-03462-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.